AGAPE ATP CORPORATION (ATPC) Operating Margin
- Operating margin · 12 months: Value -239.01%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -239.01% | Operating income / revenue. Period ending 2026-06-30. $-3.14M ÷ $1.32M × 100 ≈ -239.01% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -3.14M USD | Operating Income (Loss) |
| Revenue | 1.32M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | (m) | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-3.14M | $1.32M | (m) | (m) | (m) | -239.01% |
| 2026-03-31 | $-3.21M | $1.51M | (m) | (m) | (m) | -212.98% |
| 2025-12-31 | $-3.26M | $1.52M | (m) | (m) | (m) | -213.65% |
| 2025-09-30 | $-2.81M | $1.48M | (m) | (m) | (m) | -189.02% |
| 2025-06-30 | $-2.75M | $1.45M | (m) | (m) | (m) | -190.48% |
| 2025-03-31 | $-2.57M | $1.29M | (m) | (m) | (m) | -198.76% |
| 2024-12-31 | $-2.57M | $1.32M | (m) | (m) | (m) | -194.55% |
| 2024-09-30 | $-2.74M | $1.35M | (m) | (m) | (m) | -202.45% |
| 2024-06-30 | $-2.51M | $1.38M | (m) | (m) | (m) | -182.16% |
| 2024-03-31 | $-2.42M | $1.37M | (m) | (m) | (m) | -176.50% |
| 2023-12-31 | $-2.15M | $1.43M | (m) | (m) | (m) | -150.00% |
| 2023-09-30 | $-1.89M | $1.43M | $682.36K | (m) | (m) | -132.59% |
| 2023-06-30 | $-1.77M | $1.74M | $719.52K | (m) | (m) | -101.88% |
| 2023-03-31 | $-1.71M | $1.83M | $720.97K | (m) | (m) | -93.79% |
| 2022-12-31 | $-1.53M | $1.86M | $666.04K | (m) | (m) | -82.59% |
| 2022-09-30 | $-1.51M | $1.68M | $488.01K | (m) | (m) | -90.12% |
| 2022-06-30 | $-1.69M | $1.22M | $366.93K | (m) | (m) | -138.49% |
| 2022-03-31 | $-1.79M | $1.12M | $293.17K | (m) | (m) | -159.08% |
| 2021-12-31 | $-1.86M | $1.02M | $297.33K | (m) | (m) | -182.76% |
| 2021-09-30 | $-1.57M | $1.32M | $267.29K | (m) | (m) | -119.26% |
| 2021-06-30 | $-796.32K | $2.53M | $417.51K | (m) | (m) | -31.48% |
| 2021-03-31 | $-341.13K | $3.74M | $853.45K | (m) | (m) | -9.13% |
| 2020-12-31 | $-158.13K | $3.43M | $775.86K | (m) | (m) | -4.60% |
| 2020-09-30 | $107.77K | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-400.42K | $1.29M | $1.20M | (m) | $489.72K | -31.04% |
| 2019-09-30 | (m) | $1.37M | $1.27M | (m) | $633.02K | (m) |
| 2019-06-30 | (m) | $1.55M | $1.44M | (m) | $607.36K | (m) |
| 2019-03-31 | (m) | $1.15M | $1.04M | (m) | $156.73K | (m) |
| 2018-12-31 | (m) | $682.79K | $617.09K | (m) | $110.98K | (m) |
| 2018-09-30 | (m) | $412.25K | $375.59K | (m) | $210.92K | (m) |
| 2018-06-30 | (m) | $487.00K | $441.41K | (m) | $265.68K | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |